Photo taken from Mark Storey/Twitter
Dec 3, 2023, 16:14
Mark Storey: From asymptomatic to oligo, we remain a critical component of treatment
Mark Storey, Radiation Oncologist at the Oklahoma Proton Center, shared on X/Twitter:
“Today’s article looks at radiation in the metastatic setting – Four trials from 2023. Two with OS benefit (while SABR-COMET sits in backdrop). From asymptomatic to oligo, we remain a critical component of treatment.”
Source: Mark Storey/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 23, 2025, 01:54
Feb 23, 2025, 01:46
Feb 23, 2025, 01:42
Feb 23, 2025, 01:28
Feb 23, 2025, 00:51
Feb 23, 2025, 00:48